Minor League health and safety protocols include laboratory PCR testing of players and staff members multiple times per week. The non-invasive SDNA-1000 saliva collection device will be a critical component of MiLB’s COVID-19 health monitoring and testing plan, just as it has been since the start of MLB’s 2020 season.  During the 2020 Major League season, over 200,000 of Spectrum’s SDNA-1000 saliva collection kits were used by MLB players and personnel to help successfully monitor their health and complete a successful season. This season, over 125,000 tests have already been administered in the Majors.

Jon Coyles, MLB Vice President, Drug, Health and Safety Programs, said: “Major League Baseball is grateful to Spectrum Solutions for their continued partnership in helping us monitor the well-being of the players and staff throughout all levels of our game. The personnel of Minor League teams will receive the same unwavering commitment to safety that Spectrum’s products have created in the Majors, and we look forward to a responsible resumption of the Minor League season in 2021.”

”It’s a privilege to be baseball’s first dual-property partner as well as bring the Minor Leagues back to the game nationwide. We engineered our revolutionary saliva-based PCR testing kits for early detection accuracy and safety. No trade-offs,” said Bill Phillips, Chief Operations Officer for Spectrum Solutions.